Jeffrey R Willis

Title: The Innovations of Jeffrey R. Willis

Introduction

Jeffrey R. Willis is an accomplished inventor based in San Francisco, CA. He has made significant contributions to the field of medical technology, particularly in the treatment of age-related macular degeneration. His innovative work has led to the development of a unique patent that utilizes advanced neural network frameworks.

Latest Patents

Willis holds a patent for a "Deep neural network framework for processing OCT images to predict treatment intensity." This patent focuses on systems and methods that relate to processing optical coherence tomography (OCT) images. The technology aims to predict characteristics of treatments that can effectively address age-related macular degeneration. The process involves pre-processing the images by flattening and/or cropping them, followed by the application of a deep convolutional neural network. The output from this neural network can indicate the predicted frequency and/or interval for administering treatments, such as anti-vascular endothelial growth factor therapy, to prevent leakage of vasculature in the eye.

Career Highlights

Jeffrey R. Willis is currently employed at Genentech, Inc., a leading biotechnology company known for its innovative approaches to healthcare. His work at Genentech has allowed him to collaborate with other talented professionals in the field, enhancing the impact of his inventions.

Collaborations

Some of his notable coworkers include Michael Gregg Kawczynski and Nils Gustav Thomas Bengtsson. Their collaborative efforts contribute to the advancement of medical technologies and the development of effective treatment solutions.

Conclusion

Jeffrey R. Willis exemplifies the spirit of innovation in the medical technology sector. His patent for processing OCT images demonstrates the potential of neural networks in improving treatment outcomes for patients with age-related macular degeneration. His contributions continue to shape the future of healthcare technology.